Wexford Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-45,450
| Closed | -$24.7K | – | 277 |
|
|
2023
Q4 | $24.7K | Buy |
+45,450
| New | +$24.7K | 0.01% | 174 |
|
|
2018
Q3 | – | Sell |
-127,800
| Closed | -$1.82M | – | 171 |
|
|
2018
Q2 | $1.82M | Buy |
+127,800
| New | +$1.82M | 0.12% | 75 |
|
|
2016
Q3 | – | Sell |
-49,432
| Closed | -$286K | – | 181 |
|
|
2016
Q2 | $286K | Hold |
49,432
| – | – | 0.05% | 109 |
|
|
2016
Q1 | $299K | Buy |
+49,432
| New | +$299K | 0.06% | 95 |
|
|
2015
Q4 | – | Sell |
-67,000
| Closed | -$378K | – | 87 |
|
|
2015
Q3 | $378K | Buy |
+67,000
| New | +$378K | 0.07% | 77 |
|